We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Complex Structure and Function of Alzheimer's Enzyme

By Biotechdaily staff writers
Posted on 12 Nov 2003
A new study shows how the gamma-secretase enzyme, which has been implicated in the pathogenic process leading to Alzheimer's disease, functions at the molecular level.

Gamma-secretase, a large, complex enzyme composed of four proteins, slices amyloid precursor protein (APP) into fragments that accumulate as plaques in the brain. More...
The enzyme also interacts with the Notch protein. The core of gamma-secretase is the presenilin protein. Investigators at Washington University (St. Louis, MO, USA; www.wustl.edu) used molecular markers and specific antibodies to show that two molecules of presenilin were located in close proximity to each other. This complicated structure explained why Notch and APP were able to bind freely to the enzyme but competed for access to the cleavage site. These findings were published in the October 28, 2003, online edition of the Proceedings of the National Academy of Sciences.

"The active site is like a mouth: it chews whatever it touches but can only chew one thing at a time,” explained senior author Dr. Raphael Kopan, professor of medicine, molecular biology, and pharmacology at Washington University. "The other site is like a hand: it is used for holding, and does not interfere with the ability of the mouth to chew another object. Maybe one molecule acts as the ‘hand' serving a meal to the ‘mouth,' which is located on another molecule.”



Related Links:
Washington University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.